Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
69.1M
Number of holders
154
Total 13F shares, excl. options
49.3M
Shares change
+487K
Total reported value, excl. options
$499M
Value change
+$2.49M
Put/Call ratio
0.84
Number of buys
70
Number of sells
-65
Price
$10.12

Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q3 2023

172 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 49.3M shares of 69.1M outstanding shares and own 71.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.44M shares), BlackRock Inc. (4.94M shares), Point72 Asset Management, L.P. (3.88M shares), WELLINGTON MANAGEMENT GROUP LLP (3M shares), First Light Asset Management, LLC (2.93M shares), JPMORGAN CHASE & CO (1.98M shares), Daventry Group, LP (1.57M shares), DIMENSIONAL FUND ADVISORS LP (1.48M shares), STATE STREET CORP (1.46M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.18M shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.